Survodutide
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
Boehringer Ingelheim · Phase 3 · Completed · Enrollment 5530
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.